Seaport Therapeutics, Inc. (SPTX)
Nasdaq: SPTX · Pharmaceutical Preparations · filing with the SEC since 2024
Who runs Seaport Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Zohar Daphne
Chief Executive Officer. First filing Apr 2026, latest May 4, 2026, 0 filings in all.
Officers reporting now
5
of 27 people with a filing in the last fifteen months
Directors reporting now
22
27 people on the record since 2026
Officerssales are open-market, Nov 4, 2025 to Nov 4, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Zohar Daphne | Chief Executive Officer | Apr 2026 | May 4, 2026 | none |
| White Lauren | Chief Financial Officer | Apr 2026 | May 4, 2026 | none |
| Chen Michael Cunyuan | Chief Scientific Officer | Apr 2026 | May 4, 2026 | none |
| Loebel Antony | Chief Medical Officer | Apr 2026 | May 4, 2026 | none |
| Gladstein Lana | General Counsel | Apr 2026 | May 4, 2026 | none |
Directorssales are open-market, Nov 4, 2025 to Nov 4, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Torres Denice | director | Apr 2026 | Nov 4, 2026 | none |
| Hombach Robert J. | director | Apr 2026 | Jun 24, 2026 | none |
| Gap (Bermuda) L.P. | director | May 2026 | May 6, 2026 | none |
| Gap Coinvestments Cda, L.P. | director | May 2026 | May 6, 2026 | none |
| Gap Coinvestments III, LLC | director | May 2026 | May 6, 2026 | none |
| Gap Coinvestments IV, LLC | director | May 2026 | May 6, 2026 | none |
| Gap Coinvestments V, LLC | director | May 2026 | May 6, 2026 | none |
| General Atlantic (Lux) S.A R.L. | director | May 2026 | May 6, 2026 | none |
| General Atlantic (Sp), L.P. | director | May 2026 | May 6, 2026 | none |
| General Atlantic (Spv) Gp, LLC | director | May 2026 | May 6, 2026 | none |
| General Atlantic Genpar (Bermuda), L.P. | director | May 2026 | May 6, 2026 | none |
| General Atlantic Genpar (Lux) Scsp | director | May 2026 | May 6, 2026 | none |
| General Atlantic Genpar, L.P. | director | May 2026 | May 6, 2026 | none |
| General Atlantic Partners (Lux), Scsp | director | May 2026 | May 6, 2026 | none |
| General Atlantic Partners 100, L.P. | director | May 2026 | May 6, 2026 | none |
| General Atlantic, L.P. | director | May 2026 | May 6, 2026 | none |
| Healy James | director | Apr 2026 | May 4, 2026 | none |
| Mates Sharon | director | Apr 2026 | May 4, 2026 | none |
| Paul Steven M | director | Apr 2026 | May 4, 2026 | none |
| Peterson Sandra E | director | Apr 2026 | May 4, 2026 | none |
| Wheadon David E. | director | Apr 2026 | May 4, 2026 | none |
| Pitts Jason | director | Apr 2026 | Apr 30, 2026 | none |
Owners of more than 10% of a classsales are open-market, Nov 4, 2025 to Nov 4, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Puretech Health PLC | 10% owner | Apr 2026 | May 6, 2026 | none |
| Puretech Lyt, Inc. | 10% owner | Apr 2026 | May 6, 2026 | none |
| Arch Venture Fund Xii, L.P. | 10% owner | Apr 2026 | May 4, 2026 | none |
| Arch Venture Partners Xii, L.P. | 10% owner | Apr 2026 | May 4, 2026 | none |
| Arch Venture Partners Xii, LLC | 10% owner | Apr 2026 | May 4, 2026 | none |
| Burow Kristina | 10% owner | Apr 2026 | May 4, 2026 | none |
| Crandell Keith | 10% owner | Apr 2026 | May 4, 2026 | none |
| Gillis Steven | 10% owner | Apr 2026 | May 4, 2026 | none |
| Nelsen Robert | 10% owner | Apr 2026 | May 4, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.